Difference between revisions of "Boehringer-Ingelheim"

From Powerbase
Jump to: navigation, search
(removed logo)
Line 1: Line 1:
[[Image:Boeringher-Ingelheim.gif|thumb|right|Boehringer-Ingelheim's logo]]
 
 
 
Boehringer-Ingelheim was founded in Ingelheim, Germany, in 1885. The company under Albert Boehringer established a reputation for social enlightenment and tehnologically innovative products.).<ref>: http://www.boehringer-ingelheim.com/corporate/corp/corp_hist1_1.htm (Boehringer-Ingelheim history)</ref>  
 
Boehringer-Ingelheim was founded in Ingelheim, Germany, in 1885. The company under Albert Boehringer established a reputation for social enlightenment and tehnologically innovative products.).<ref>: http://www.boehringer-ingelheim.com/corporate/corp/corp_hist1_1.htm (Boehringer-Ingelheim history)</ref>  
 
Boehringer introduced benefits to his workforce deemed 'remarkably enlightened and generous for the time', including a health insurance scheme in 1902, annual holiday entitlement employee travel subsidiaries in 1910, and a company pension in 1912.<ref>http://www.boehringer-ingelheim.com/corporate/corp/corp_hist1_1_3.htm (Boehringer-Ingelheim, Social Welfare Pioneer),</ref>  
 
Boehringer introduced benefits to his workforce deemed 'remarkably enlightened and generous for the time', including a health insurance scheme in 1902, annual holiday entitlement employee travel subsidiaries in 1910, and a company pension in 1912.<ref>http://www.boehringer-ingelheim.com/corporate/corp/corp_hist1_1_3.htm (Boehringer-Ingelheim, Social Welfare Pioneer),</ref>  
Line 7: Line 5:
  
 
Boehringher Ingelheim took $10.84B in global sales and spent $1,148M on research and design in 2005.<ref>Gray, N. (2006) Changing Landscapes: A special Report on the World’s Top 50 Pharma Companies, Pharmaceutical Executive. Available online at: pharmexec.findpharma.com/pharmexec/2005-Pharm-Exec-50-revised/ArticleStandard/Article/detail/354138 </ref>
 
Boehringher Ingelheim took $10.84B in global sales and spent $1,148M on research and design in 2005.<ref>Gray, N. (2006) Changing Landscapes: A special Report on the World’s Top 50 Pharma Companies, Pharmaceutical Executive. Available online at: pharmexec.findpharma.com/pharmexec/2005-Pharm-Exec-50-revised/ArticleStandard/Article/detail/354138 </ref>
 
 
 
 
 
  
 
==Lobbying and PR firms==
 
==Lobbying and PR firms==

Revision as of 14:24, 10 June 2009

Boehringer-Ingelheim was founded in Ingelheim, Germany, in 1885. The company under Albert Boehringer established a reputation for social enlightenment and tehnologically innovative products.).[1] Boehringer introduced benefits to his workforce deemed 'remarkably enlightened and generous for the time', including a health insurance scheme in 1902, annual holiday entitlement employee travel subsidiaries in 1910, and a company pension in 1912.[2]

Boehringer-Ingelheim Pharmaceuticals focuses largely on human pharmaceuticals (prescription medicines, consumer health care and biopharmaceuticals. Specific areas of interest are: acute coronary disease, arthritis, COPD, HIV/AIDS, Hypertension, Parkinson’s Disease, Restless Legs Syndrome, Stoke and Thromboembolic Diseases. Wellknown products include Antistax, Buscopan and Dulcolax.[3]

Boehringher Ingelheim took $10.84B in global sales and spent $1,148M on research and design in 2005.[4]

Lobbying and PR firms

Notes

  1. : http://www.boehringer-ingelheim.com/corporate/corp/corp_hist1_1.htm (Boehringer-Ingelheim history)
  2. http://www.boehringer-ingelheim.com/corporate/corp/corp_hist1_1_3.htm (Boehringer-Ingelheim, Social Welfare Pioneer),
  3. http://www.boehringer-ingelheim.com/corporate/products/index.asp (Boehringer-Ingelheim products)
  4. Gray, N. (2006) Changing Landscapes: A special Report on the World’s Top 50 Pharma Companies, Pharmaceutical Executive. Available online at: pharmexec.findpharma.com/pharmexec/2005-Pharm-Exec-50-revised/ArticleStandard/Article/detail/354138